Disease Overview：Nongonococcal Urethritis（NGU）
Non-gonococcal urethritis (NGU) is a common urological infection in men, characterized by urethral inflammation without evidence of *Neisseria gonorrhoeae*. It is most frequently caused by *Chlamydia trachomatis* or *Mycoplasma genitalium*, though other pathogens—including *Ureaplasma* species and, less commonly, herpes simplex virus or *Trichomonas vaginalis*—may be implicated. Symptoms typically include dysuria, urethral discharge, and urethral pruritus or irritation; however, up to 50% of cases may be asymptomatic, increasing the risk of complications such as epididymitis, prostatitis, or reactive arthritis if left untreated. Diagnosis relies on nucleic acid amplification tests (NAATs) targeting *C. trachomatis* and *M. genitalium*, supplemented by microscopy and culture where indicated. First-line therapy involves azithromycin or doxycycline, with tailored regimens for resistant or recurrent cases based on antimicrobial susceptibility testing.
China offers distinct advantages for NGU management: its tertiary urology centers house internationally trained specialists with extensive experience in sexually transmitted infection (STI) diagnostics and antimicrobial stewardship. Advanced molecular diagnostics—including multiplex PCR and next-generation sequencing—are widely deployed for precise pathogen identification and resistance profiling. Clinical outcomes are robust, with >95% resolution rates in compliant patients across major hospitals in Beijing, Shanghai, and Guangzhou. Treatment costs remain significantly lower than in the US, UK, or Australia—often 40–60% less—without compromising quality or regulatory compliance. As a dedicated medical tourism agency, we facilitate seamless care for international patients: coordinating appointments with certified urologists, verifying transparent all-inclusive pricing, arranging visa support and accommodation, and providing bilingual clinical liaison services from diagnosis through follow-up.
Nongonococcal Urethritis: treatment in China helps patients compare specialist hospitals, initial assessment steps and estimated costs that may vary by city, institution and clinical condition.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Non-Gonococcal Urethritis (Male)
Non-Surgical / Conservative / Medication Options
*Target Criteria:* Confirmed *Chlamydia trachomatis* or *Mycoplasma genitalium* infection via NAAT; mild-to-moderate symptoms (dysuria, urethral discharge); no treatment failure or resistance history.
- •First-Line Therapy (Tier 1 – Standard)
- Urine NAAT (Chlamydia/Mycoplasma): $28–$42 - Urinalysis + microscopy: $8–$12 - Total (meds + diagnostics): $65–$95
- •Second-Line Therapy (Tier 2 – Resistance Suspected/Confirmed)
- Confirmatory *M. genitalium* PCR + macrolide resistance testing (23S rRNA): $75–$110 - Liver function test (pre-moxifloxacin): $15–$22 - Total (meds + advanced diagnostics): $145–$210
- •Adjunctive Care
- Follow-up NAAT at 3 weeks (test-of-cure): $28–$42
Surgical / Procedural / Interventional Options
*Eligibility Criteria:* Chronic/recurrent NGU (>3 episodes/year) with documented persistent infection despite ≥2 guideline-concordant regimens *and* exclusion of reinfection (partner testing confirmed negative); evidence of urethral stricture on uroflowmetry/cystoscopy.
- •Diagnostic Cystourethroscopy (Pre-procedure workup required)
- Cystourethroscopy (flexible scope, outpatient): $180–$265 - Biopsy (if mucosal abnormality seen): $45–$68
- •Urethral Calibration/Dilation (for stricture-related NGU)
- OR operating room dilation under local anesthesia: $220–$330
Special / Complex Condition Options
- •Refractory NGU with *M. genitalium* fluoroquinolone resistance:
- Therapeutic drug monitoring (serum levels): $195–$285
- •HIV-coinfected patients: Enhanced monitoring (CD4/viral load + repeat NAAT): +$135–$200
Quick Selection Guide
- •Young adult (<35), first episode, budget <$100: Tier 1 therapy ($65–$95) — optimal efficacy, minimal cost.
- •Age >45, recurrent NGU, comorbid diabetes/hypertension: Tier 2 + LFT ($145–$210) — avoids doxycycline GI risks and ensures resistance detection.
- •Chronic NGU (>1 year), failed 3 regimens, suspected stricture: Cystourethroscopy ($180–$265) + calibration ($85–$125) — targets structural contributor.
- •HIV+ or immunocompromised: Full Tier 2 + HIV-specific monitoring ($280–$410) — prevents complications from delayed clearance.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Nongonococcal Urethritis Medical Vacation Packages
Curated transparent all-inclusive packages combining Nongonococcal Urethritis treatment with China top medical destinations:
